Stocks to Watch: Invitae Corporation (NYSE:NVTA), Agenus Inc. (NASDAQ:AGEN), Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), Perma-Fix Environmental Services (NASDAQ:PESI), Encore Wire (NASDAQ:WIRE)

On Monday shares of Invitae Corporation (NYSE:NVTA) closed at $15.40. Invitae Corp. (NYSE:NVTA) on 12 May, reported a loss of $18.6 million in its first quarter. The San Francisco-based company said it had a loss of $1.09 per share. The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 51 cents per share. The genetic testing company posted revenue of $1.2 million in the period.

Agenus Inc. (NASDAQ:AGEN) in last trading activity moved down -1.45% to close at $6.80. Company weekly performance is 1.04% while its quarterly performance stands at 31.78%. Agenus Inc. (NASDAQ:AGEN) is -15.00% away from its 52 week high. On 15 May, Agenus Inc. (NASDAQ:AGEN) announced data on continuing survival from a phase II study on its cancer vaccine candidate, prophage, which is being developed for the treatment of glioblastoma multiforme (GBM). The data from the study will be presented orally at the annual meeting of the American Society of Clinical Oncology.

On Monday shares of Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) closed at $9.69. Company’s sales growth for last 5 years was 3.60% and EPS growth for next 5 years is recorded as 10.27%. Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) approved the sale of up to 3 billion reais ($1 billion) in debentures on the local debt market in 2015, the company said in a filing late Friday. Petrobras has no specific timeline for the transaction, which will depend on market conditions.

Perma-Fix Environmental Services Inc. (NASDAQ:PESI) has 6.10% insider ownership while its institutional ownership stands at 39.80%. In last trading activity company’s stock closed at $3.55. Perma-Fix Environmental Services, Inc. (NASDAQ: PESI), on 8 May announced that Perma-Fix Medical S.A., a subsidiary of the company, has formally accepted the grant awarded earlier this year to a consortium it led for further development and commercialization of a novel prototype generator for the production of Technetium-99m (“Tc-99m”) for use in cancer and cardiac imaging (“Generator Project”). The grant was awarded under the STRATEGMED Program in Poland.

On last trading day Encore Wire Corp. (NASDAQ:WIRE) advanced 0.88% to close at $44.90. Its volatility for the week is 2.45% while volatility for the month is 3.14%. WIRE’s sales growth for past 5 years was 12.40% and its EPS growth for past 5 years was 61.90%. Encore Wire Corp. (NASDAQ:WIRE) monthly performance is 12.90%. TheStreet upgraded shares of Encore Wire Corp. (NASDAQ:WIRE) from a “hold” rating to a “buy” rating in a research note.

Leave a Reply

Your email address will not be published. Required fields are marked *

*